scispace - formally typeset
C

Christopher J. Donahue

Researcher at Genentech

Publications -  13
Citations -  4189

Christopher J. Donahue is an academic researcher from Genentech. The author has contributed to research in topics: Apoptosis & Stem cell. The author has an hindex of 11, co-authored 13 publications receiving 4102 citations.

Papers
More filters
Journal ArticleDOI

Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family *

TL;DR: Results suggest that, along with other family members such as Fas/Apo-1 ligand and TNF, Apo-2L may serve as an extracellular signal that triggers programmed cell death.
Journal ArticleDOI

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

TL;DR: Certain tumours may escape FasL-dependent immune-cytotoxic attack by expressing a decoy receptor that blocks FasL, which was amplified in about half of 35 primary lung and colon tumours studied and DcR3 messenger RNA was expressed in malignant tissue.
Journal ArticleDOI

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB

TL;DR: Apo-3 is identified as a third member of the TNFR family that activates apoptosis, and it is suggested that Apo-3, TNFR1 and CD95 engage a common apoptotic cell-death machinery.
Journal ArticleDOI

In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells

TL;DR: The experiments show that the megakaryocytopoietic and thrombopoetic activities of TPO are initiated at the level of an early progenitor cell or upon the hematopoietIC stem cell.
Journal ArticleDOI

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA

TL;DR: It is shown that Apo-21, activated apoptosis in T-cell-enriched cultures of peripheral blood lymphocytes stimulated by interleukin-2 (IL-2), but not in unstimulated cells, which suggests that, like Fas/Apo-1 ligand and TNF, Api-2L may play a role in regulating post-stimulation apoptosis of mature lymphocytes.